Product development
Product structures are developed around controlled manual needle retraction and single-use disablement.
Sobre a Xingxu Kangda
A Shaanxi Xingxukangda Medical Technology desenvolve e fabrica seringas de segurança retráteis estéreis e soluções automatizadas relacionadas.

Perfil da empresa
A Xingxu Medical Devices (Suzhou) foi fundada em 2016. Em 2023 foi criada uma operação em Lintong, Shaanxi, focada no desenvolvimento e produção de seringas de segurança.
A operação integra P&D, moldes de precisão, montagem automatizada, processos limpos e fornecimento B2B internacional.
Integrated company scope
Xingxu Kangda brings several connected capabilities together around retractable safety syringe development and manufacturing.
Product structures are developed around controlled manual needle retraction and single-use disablement.
Mold development supports the geometry and repeatability required by syringe components.
Assembly equipment and process design connect product development with scalable manufacturing.
Product information, videos and available documents support distributor and institutional evaluation.
Working principles
The company profile is strengthened by showing how technical and commercial discussions are approached.
Product conversations begin with structure, capacity, needle specification and intended market.
Available product videos, certificates and patent documents are presented for direct review.
Buyers can reach the product team through the inquiry form, email or WhatsApp.
Public records in China
The following milestones link to Chinese corporate, media and regulatory records. Planned capacity and project figures are presented as reported at the time, not as current supply commitments.
Public corporate information records Shaanxi Xingxukangda Medical Technology Co., Ltd. as established in Xi'an on 3 April 2023.
Corporate registration recordA Lintong media report stated that phase one of the Xingxu medical-engineering project entered production with two safety-syringe lines.
View public source ↗2024.1003Shaanxi Daily reported a RMB 113 million cooperation project covering hot-runner molds and automated retractable self-disable syringe lines.
View public source ↗2026.0104Shaanxi Medical Products Administration listed a Class II registration for a single-use human venous blood specimen collection container under the company name.
View public source ↗Certificação de qualidade e patentes internacionais
Consulte o certificado ISO 13485 e documentos selecionados de patentes internacionais fornecidos pela Xingxu Kangda.

Certificado 05135233 0001 Rev. 00 para projeto, desenvolvimento, produção e distribuição de seringas estéreis retráteis autodestrutivas.
Ver PDF original →
Documento de patente de seringa segura; titular indicado: LU, WEN-CHIN.
Ver PDF original →
Patente IDP000069186 - SAFE SYRINGE; titular indicado: LU, WEN-CHIN.
Ver PDF original →
Documento europeu de procedimento de patente para tecnologia de seringa segura.
Ver PDF original →
Patente No. 18823 - Safe syringe; titular indicado: LU, WEN-CHIN.
Ver PDF original →